These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7427177

  • 1. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.
    Hillary IB, Griffith AH.
    Br Med J; 1980 Jun 28; 280(6231):1580-1. PubMed ID: 7427177
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS, Han YR, Su WN, Chen J, Zhao K.
    Vaccine; 1984 Dec 28; 2(4):277-80. PubMed ID: 6531968
    [Abstract] [Full Text] [Related]

  • 4. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG, Metelli R, Valensin PE.
    Arch Virol; 1989 Dec 28; 106(1-2):63-72. PubMed ID: 2764728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB, Freestone DS.
    J Hyg (Lond); 1975 Dec 28; 75(3):407-11. PubMed ID: 1059708
    [Abstract] [Full Text] [Related]

  • 7. Rubella vaccination: persistence of antibodies for 10-21 years.
    O'Shea S, Woodward S, Best JM, Banatvala JE, Holzel H, Dudgeon JA.
    Lancet; 1988 Oct 15; 2(8616):909. PubMed ID: 2902357
    [No Abstract] [Full Text] [Related]

  • 8. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA, Heywood SN, Laughton E, Gould JJ, Freestone DS.
    J Hyg (Lond); 1977 Jun 15; 78(3):419-27. PubMed ID: 266542
    [Abstract] [Full Text] [Related]

  • 9. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H, Tobin JO, Cradock-Watson JE, Lomax J.
    J Hyg (Lond); 1978 Jun 15; 80(3):337-47. PubMed ID: 649946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rubella vaccine in the People's Republic of China.
    Han YR, Zhao K, Gong YX, Hao SL, Wang SZ, Wang CT.
    Rev Infect Dis; 1985 Jun 15; 7 Suppl 1():S79. PubMed ID: 4001739
    [Abstract] [Full Text] [Related]

  • 12. Fetomaternal apects of immunization with RA27/3 live attenuated rubella virus vaccine during pregnancy.
    Bernstein DI, Ogra PL.
    J Pediatr; 1980 Sep 15; 97(3):467-70. PubMed ID: 7411312
    [No Abstract] [Full Text] [Related]

  • 13. Identification of rubella virus T-cell epitopes recognized in anamnestic response to RA27/3 vaccine: associations with boost in neutralizing antibody titer.
    Mitchell LA, Tingle AJ, Décarie D, Shukin R.
    Vaccine; 1999 May 14; 17(19):2356-65. PubMed ID: 10392617
    [Abstract] [Full Text] [Related]

  • 14. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM, Schluederberg A, Emmons JE, Evans BK, Randolph MF, Andiman WA.
    Rev Infect Dis; 1985 May 14; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [Abstract] [Full Text] [Related]

  • 15. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A, Fanti O, Rossolini GM, Cellesi C.
    Boll Ist Sieroter Milan; 1985 May 14; 70(1-2):443-8. PubMed ID: 1670047
    [Abstract] [Full Text] [Related]

  • 16. Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines.
    Yang MH, Freitas ARR.
    Math Biosci Eng; 2019 Apr 12; 16(4):3195-3214. PubMed ID: 31499609
    [Abstract] [Full Text] [Related]

  • 17. Rubella vaccines and the immunity gap.
    Andre FE, Florent G, du Pan RM.
    Lancet; 1979 Aug 25; 2(8139):417-8. PubMed ID: 89471
    [No Abstract] [Full Text] [Related]

  • 18. Antibody response to rubella ribonucleoprotein component after natural infection and after immunization.
    Ho-Terry L, Cohen A.
    J Med Microbiol; 1981 Feb 25; 14(1):141-5. PubMed ID: 7463463
    [Abstract] [Full Text] [Related]

  • 19. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines].
    Imbs D, Kańtoch M, Rudnicka H, Niedźwiedzka-Adamaszek E, Pychyńska A, Zegadło W, Stempień R, Słowińska I, Kretkowska A.
    Przegl Epidemiol; 1987 Feb 25; 41(2):141-8. PubMed ID: 3423282
    [No Abstract] [Full Text] [Related]

  • 20. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M.
    Biken J; 1986 Dec 25; 29(3-4):63-71. PubMed ID: 3304276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.